TECH BUYER Jul 2021 - IDC Perspective - Doc # EUR148058821
Managing Cyber-Risks Across the Digital Transformation Journey: How Debiopharm is Undertaking a Security Transformation
This IDC Perspective illustrates how Debiopharm (a Swiss biopharmaceutical company) embarked on a digital transformation journey in which cybersecurity has become a top priority. This report highlights the key elements of this journey, including the adoption of artificial intelligence solutions to protect the intellectual property of its business against cyberattacks.
"The life sciences landscape is experiencing dynamic changes that require a flexible and secure operating model. While pursuing their digital transformation journey, pharma companies must have cybersecurity strategies. This case study demonstrates the value of a cybersecurity solution offered by an expert and trusted vendor that has become essential for the pharma company," said Adriana Allocato, research manager, IDC Health Insights.
Analytic applications, Business transformation, Cognitive/artificial intelligence, Digital transformation, Information protection and control, Messaging security, Network security, Security management, Technology buyer